(Q30414865)

English

Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

vector-borne disease

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Falko Schmeisser

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Joan E Adamo

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Benjamin Blumberg

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Rachel Friedman

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jacqueline Muller

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jackeline Soto

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Jerry P Weir

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

29 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

3413-3422

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Plasmid-driven formation of influenza virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza virus matrix protein is the major driving force in virus budding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza virus-like particle vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza vaccines based on virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.03.033

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30414865&oldid=1655125544"